香港快运完成数字健康护照CommonPass测试
香港快运(HK Express)公布,为准备迎接旅游新常态,近日已完成数字健康护照CommonPass应用程式的首次测试。该应用程式可安全验证及储存用户的新型冠状病毒病检测结果与疫苗接种记录,核实并确认各国入境要求,方便旅客掌握出境程序。
香港快运於5月6日由香港飞往台中的UO172航班进行测试,机师及机组人员属自愿参与,透过建立用户个人档案,并在起飞前24至72小时进行病毒快速测试,由指定化验所Prenetics进行样本化验,应用程式在於24小时内取得检测结果,以作识别。为保障个人私隐,CommonPass只会将用户的个人识别资料和有限的新型冠状病毒病相关记录储存於个人设备上。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.